Dynacirc and Pain exacerbated - a phase IV clinical study of FDA data

Summary:

Pain exacerbated is reported as a side effect among people who take Dynacirc (isradipine), especially for people who are female, 60+ old, also take Norvasc, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Pain exacerbated when taking Dynacirc. It is created by eHealthMe based on reports of 959 people who have side effects when taking Dynacirc from the FDA, and is updated regularly.

What is Dynacirc?

Dynacirc has active ingredients of isradipine. eHealthMe is studying from 975 Dynacirc users. Check the latest studies of Dynacirc.

What is Pain exacerbated?

Pain exacerbated is found to be associated with 3,978 drugs and 3,033 conditions by eHealthMe. Check the latest studies of Pain exacerbated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

959 people reported to have side effects when taking Dynacirc.
Among them, 63 people (6.57%) have Pain exacerbated.

Among these 63 people:

What is the gender of people who have Pain exacerbated when taking Dynacirc? *

female: 58.73 %
male: 41.27 %

What is the age of people who have Pain exacerbated when taking Dynacirc? *

What are other drugs people take besides Dynacirc? *

What are other side effects people have besides Pain exacerbated? *

Acute Kidney Failure: 27 people, 42.86%
Weakness: 23 people, 36.51%
Stress And Anxiety: 23 people, 36.51%
Back Pain: 22 people, 34.92%
Rashes (redness): 22 people, 34.92%
Abdominal Discomfort: 20 people, 31.75%
Discomfort: 20 people, 31.75%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 19 people, 30.16%
Bone Pain: 19 people, 30.16%
Osteonecrosis Of Jaw (death of bone of jaw): 19 people, 30.16%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 19 people, 30.16%
Multiple Allergies (allergy to multiple agents): 8 people, 12.70%
Anaemia (lack of blood): 7 people, 11.11%
Asthma: 7 people, 11.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 11.11%
High Blood Pressure: 7 people, 11.11%
Osteoporosis (bones weak and more likely to break): 6 people, 9.52%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 7.94%
Cardiac Failure Congestive: 3 people, 4.76%
Depression: 3 people, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Dynacirc and have Pain exacerbated?

- Check whether Pain exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dynacirc:

Dynacirc (975 reports)

Browse all side effects of Dynacirc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pain exacerbated:

Pain exacerbated (3,978 drugs)

Browse all the conditions that are associated with Pain exacerbated:

Pain exacerbated (3,033 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on isradipine (the active ingredients of Dynacirc) and Dynacirc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.